说明:
此信息由前程无忧(51JOB)审核并发布(查看原发布网址),应届生求职网转载该信息只是出于传递更多就业招聘信息,促进大学生就业的目的。如您对此转载信息有疑义,请与原信息发布者前程无忧(51JOB)核实,并请同时联系本站处理该转载信息。
专业1:基础医学
专业2:药学
职能类别:其他
JD:
Translation duty
- Plan, schedule and monitor translation projects.
- Proofread and perform quality checks on translated files.
- Translate and review, verify clinical documents, proofread/enter proofreader’s corrections, check consistency and format.
- Embrace new technologies and changes in this industry to continuously improve one’s own translation skillset.
Process management
- Manage the public email account of medical translation.
- Maintain the translation glossary and translation memory for Clin Dev.
Internal and external communication
- Effectively communicate with internal stakeholders, professionals and colleagues to ensure high quality translation.
- Respond in a timely and professional manner to any query concerning translation.
- Communicate updated messages concerning clinical document translation with external translation service providers to ensure the quality of deliverables.
Requirement:
- Master or above majoring in medical, biology, pharmacy, or other life science related areas or majoring in translation with strong medical or life science related background;
- High level of English proficiency, especially an excellent command of written English;
- Ability to prioritize tasks, and deliver high-quality translation according to tight timelines and shifting priorities/demands;
- Independently motivated with good problem-solving ability;
- A good team player with integrity;
- Ability to understand, interpret, and translate clinical and scientific data;
- Technical expertise in Microsoft Word, Adobe Acrobat, Trados and other Computer Aided Translation software
公司简要介绍:
公司名称:百济神州(北京)生物科技有限公司
公司类型:上市公司
公司介绍:百济神州是一家总部设在北京的中国生命科学生物科技公司,致力于探索和开发对中国和亚太地区常见癌症有效的新型抗肿瘤药物。
我们的研发策略将包括开发我们自己在中国实验室发现的新药和从合作伙伴引进的对中国和亚太地区常见癌症有潜在疗效的新药。
为完善我们的研发能力,百济神州正在中国创造一个从实验室到临床试验的强大整合研发平台,用于识别癌症患者中最有可能受益于相关药物或治疗方法的病人亚群。通过理解对药物的敏感性和靶标分子之间的关系, 我们将会研发出更有效和更安全的新药。
我们正在以下领域建立杰出的团队:
1.全新的小分子药物和生物药物的研发
2.侧重于在患者中对生物标志物识别和确认的转化研究
3.基于人类肿瘤基因分型和基因表达谱的生物信息学
4.临床开发
以下几个方面实力的结合带给我们独特的优势:
1.中国和西方的研发知识和临床实践
2.大制药公司的严谨性和稳健性与小生物技术公司的创业精神
3.中国和西方的创业文化